What Is Calcium Oxalate Monohydrate?

Define Calcium Oxalate Monohydrate, the stable mineral behind 80% of kidney stones, covering its chemistry, diet management, and natural role.

Calcium oxalate monohydrate, often abbreviated COM, is a crystalline compound made of calcium, oxalate, and a single water molecule per unit. It is the most common mineral found in human kidney stones, and it also shows up across the natural world in plants, lichens, and even industrial equipment. Knowing what COM actually is, how it forms, and why your body sometimes makes too much of it opens the door to understanding kidney stone prevention, certain poisoning cases, and a few rare genetic conditions.

The Compound Itself

Calcium oxalate monohydrate goes by the mineral name whewellite when geologists find it in rocks or biological specimens. The “monohydrate” part simply means each formula unit of calcium oxalate holds one molecule of water in its crystal lattice. A close relative, calcium oxalate dihydrate (COD, mineral name weddellite), holds two water molecules and forms a different crystal shape. Of the two, COM is more thermodynamically stable, which is a fancy way of saying it is the form that nature prefers over time. COD crystals that form first in a solution tend to convert into COM crystals if given the chance. That stability matters a great deal inside the kidney, because COM crystals are harder to dissolve and more likely to stick around and grow into stones.

COM crystals are practically insoluble in water. You can think of calcium oxalate as what happens when calcium and oxalic acid meet in a liquid environment and lock together so tightly that they drop out of solution. This is why it forms deposits rather than floating harmlessly: once calcium and oxalate combine, the resulting crystal resists being pulled back apart by ordinary body fluids.

Where COM Shows Up in Nature

Plants are prolific manufacturers of calcium oxalate monohydrate. Many species produce needle-shaped COM crystals called raphides inside specialized cells. These raphides serve double duty. First, they help the plant manage excess calcium by locking it into an insoluble form and storing it safely in vacuoles. Second, they function as a physical defense against herbivores: when an insect or animal bites into the tissue, bundles of tiny needles puncture the attacker’s mouth and deliver irritating compounds through the wounds. Raphides range from about 16 to 300 micrometers long depending on the species, and they are found most abundantly in leaves and stems.

Research in banana plants has shown that the formation of these raphides is a carefully choreographed process: vesicles carrying amorphous calcium oxalate travel along tiny protein tracks inside the cell, then fuse with a membrane-bound compartment where proteins act as a template, guiding the crystals into their elongated needle shape. This is why eating raw taro or certain aroids causes that sharp burning sensation in your mouth: you are literally being poked by thousands of microscopic COM needles.

Beyond plants, lichens also produce calcium oxalate monohydrate. Studies of lichens growing on travertine rock have identified whewellite crystals in some species and weddellite in others, suggesting that different organisms favor different hydration forms depending on their biology and environment.

COM and Kidney Stones

The reason most people encounter the term “calcium oxalate monohydrate” is kidney stones. COM is the single most common crystal type found in kidney stones removed from adults. When urine becomes supersaturated with calcium and oxalate, tiny COM crystals nucleate, and if conditions allow them to stick to kidney tissue and keep growing, a stone eventually forms.

A leading theory about how this process gets started involves Randall’s plaques, which are small deposits of calcium phosphate that form in the tissue lining the kidney. These plaques can erode through the surface and become exposed to urine, and COM crystals preferentially nucleate on them. Researchers have observed a range of crystal shapes at the plaque-stone interface, from neatly stacked platelets to chaotic, porous structures, reflecting different degrees of supersaturation in the surrounding urine at the time of crystal formation. Laboratory experiments have even shown that under conditions mimicking urine chemistry, the calcium phosphate in Randall’s plaques can be partly replaced by COM, turning the plaque itself into the seed of a stone.

Once crystals form, whether they become a problem depends on whether they stick to the kidney lining. Healthy, intact tubular cells are remarkably good at resisting crystal adhesion: lab studies show that when kidney cells form a tight, fully intact layer, almost no COM crystals bind to the surface. But when cells are injured or still healing from a wound, crystal binding jumps dramatically. The crystals that do adhere can then cause further cell damage, which invites more crystals to attach, creating a self-reinforcing cycle. Your body counters this with natural crystal inhibitors. One of the most potent is a protein found in urine called osteopontin, which can latch onto growing COM crystals and slow or halt their expansion.

Not All COM Stones Are the Same

It might seem like a kidney stone is a kidney stone, but the internal structure and surface appearance of COM stones vary, and those differences carry real clinical meaning. Researchers classify COM stones into several morphological types. Most types have a relatively moderate recurrence rate: about 38% of COM stone patients had experienced a previous episode. But one particular subtype, called type Ic, which has a light color, a bumpy surface, and a disorganized internal structure, recurred at a rate of over 80%. This means that when a urologist analyzes a stone’s composition and shape, the findings can actually predict how aggressively to pursue prevention strategies.

Metabolic profiling adds another layer. People who form COM stones tend to have a different urinary chemistry from those who form COD stones. In one clinical study, about 28% of COM stone formers had elevated urinary oxalate levels compared to only about 7% of COD stone formers. That distinction matters because it can guide whether a doctor focuses treatment on reducing oxalate excretion, adjusting calcium intake, or both.

Diet, Calcium, and Oxalate Absorption

Here is where popular understanding often goes wrong. Many people hear “calcium oxalate stones” and assume they should cut calcium from their diet. The opposite is closer to the truth. When you eat calcium alongside oxalate-containing foods, the calcium binds to oxalate in the gut, forming insoluble calcium oxalate that passes harmlessly through your digestive system instead of being absorbed into the blood and eventually filtered into your urine. Restricting calcium actually frees up more oxalate for absorption, increasing the amount that reaches your kidneys.

The numbers bear this out. In healthy volunteers, when daily calcium intake was around 200 mg (quite low), about 17% of ingested oxalate was absorbed. When calcium intake rose to 1,200 mg per day, absorption dropped to roughly 3%. That is a fivefold reduction simply from eating enough calcium. Beyond about 1,200 mg per day, additional calcium still reduced absorption, but the benefit was much smaller.

The form of oxalate in food also matters. Only the soluble fraction of oxalate can be absorbed, and that fraction depends on pH and the concentrations of calcium and magnesium in the gut at each point along the intestinal tract. Not all high-oxalate foods raise urinary oxalate equally. Research has identified a relatively short list of foods that significantly increased urinary oxalate excretion in volunteers: spinach, rhubarb, beets, nuts, chocolate, tea, wheat bran, and strawberries. Many other foods contain oxalate but do not move the needle much in practice.

The Gut Bacteria That Eat Oxalate

Your intestinal tract harbors a bacterium called Oxalobacter formigenes that lives exclusively on oxalate as its food source. By breaking down oxalate in the gut, this organism reduces the amount available for absorption into the bloodstream and ultimately into the urine. Not everyone carries healthy populations of this bacterium, and antibiotic use can wipe it out, which may partly explain why some people are more prone to high urinary oxalate than others.

Researchers have been exploring whether deliberately colonizing the gut with O. formigenes could protect against kidney stones. In a study of healthy adults, successful colonization reduced stool oxalate by about 54% and urinary oxalate by a mean of 14% compared to the pre-colonization state on the same high-oxalate diet. The responses varied considerably between individuals, so this is not yet a clinical solution, but it represents a genuinely different approach to the problem: instead of changing what you eat, change what your gut does with what you eat.

Potassium Citrate and Stone Prevention

Citrate is one of the body’s own weapons against COM crystallization. In urine, citrate binds to calcium, reducing the amount of free calcium available to pair with oxalate. It also directly inhibits the growth and aggregation of COM crystals. When stone patients took potassium citrate supplements, urinary pH rose and the tiny crystals that did form in urine became smaller, less aggregated, and shifted partly away from COM toward the less troublesome COD form.

In a long-term trial of patients with high uric acid excretion who were forming calcium oxalate stones, potassium citrate supplementation dropped the stone formation rate from about 1.6 stones per patient per year to about 0.4, and stones stopped forming entirely in most of the treated patients. This is one of the best-established medical treatments for recurrent calcium oxalate stones and is something you can discuss with a nephrologist or urologist if you have had more than one episode.

When COM Signals Something More Serious

Occasional kidney stones, while painful, are usually a manageable problem. But in some situations, calcium oxalate monohydrate deposits are a sign of a deeper issue. Two stand out.

The first is ethylene glycol poisoning. Ethylene glycol, found in antifreeze, is metabolized in the body ultimately to oxalic acid, which then precipitates as COM crystals inside the kidneys. The resulting crystal accumulation directly injures the cells lining the kidney tubules and can lead to acute kidney failure. The kidney damage is closely linked to the degree of COM crystal accumulation, and the mechanism involves crystals being internalized by tubular cells. Finding COM crystals in the urine of a patient who presents with unexplained kidney failure is a classic diagnostic clue for ethylene glycol ingestion.

The second situation is primary hyperoxaluria, a group of inherited disorders in which a defective liver enzyme causes the body to overproduce oxalate. The oxalate load can overwhelm the kidneys, leading to recurrent stones beginning in childhood. When the kidneys can no longer keep up, calcium oxalate begins depositing throughout the body in a process called systemic oxalosis, affecting bones, eyes, skin, and the heart. Historically, the only definitive treatment for severe forms was a combined liver-kidney transplant. More recently, RNA-based therapies have been developed to silence the gene responsible for excess oxalate production, which has changed the landscape for some patients.

COM in Cats and Other Animals

Calcium oxalate stones are not exclusively a human problem. In cats, calcium oxalate urolithiasis has become one of the most frequently diagnosed stone types, and stones lodged in the ureter (the tube connecting the kidney to the bladder) can be life-threatening because a cat’s ureter is tiny and easily blocked. Unlike struvite stones, which can sometimes be dissolved with diet changes, calcium oxalate stones in cats typically require surgical or interventional removal. The rise in feline COM stones over the past few decades has paralleled changes in commercial cat food formulation, though the exact dietary drivers are still debated among veterinary researchers.

Industrial Scale Problems

COM is not just a biological nuisance. In several industries, calcium oxalate scale builds up on equipment surfaces and is notoriously hard to remove. Pulp and paper manufacturing is a well-known example: during the bleaching process, oxalate released from wood fibers meets calcium in the process water and precipitates as a rock-hard scale on pipes and machinery. Sugar evaporators and alcohol production facilities face similar problems. The downtime required to scrape or dissolve these deposits is expensive and disrupts production, driving ongoing research into chemical inhibitors that can keep COM from forming on surfaces. The same fundamental insolubility that makes COM such a persistent problem in the kidney makes it equally stubborn on an industrial heat exchanger.